[{"address1": "21 Business Park Drive", "city": "Branford", "state": "CT", "zip": "06405", "country": "United States", "phone": "203 646 6446", "website": "https://azitrainc.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.", "fullTimeEmployees": 10, "companyOfficers": [{"maxAge": 1, "name": "Mr. Francisco D. Salva", "age": 52, "title": "President, CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 427030, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Travis M. Whitfill M.P.H., Ph.D.", "age": 33, "title": "Co-Founder, COO & Director", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 161613, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Norman  Staskey", "age": 53, "title": "CFO, Treasurer & Secretary", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 314025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark  Sampson", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.2234, "open": 0.22, "dayLow": 0.2201, "dayHigh": 0.229, "regularMarketPreviousClose": 0.2234, "regularMarketOpen": 0.22, "regularMarketDayLow": 0.2201, "regularMarketDayHigh": 0.229, "forwardPE": -0.3008, "volume": 62427, "regularMarketVolume": 62427, "averageVolume": 390841, "averageVolume10days": 624400, "averageDailyVolume10Day": 624400, "bid": 0.2251, "ask": 0.226, "bidSize": 900, "askSize": 1100, "marketCap": 6489294, "fiftyTwoWeekLow": 0.2, "fiftyTwoWeekHigh": 5.18, "priceToSalesTrailing12Months": 10.358011, "fiftyDayAverage": 0.952, "twoHundredDayAverage": 1.8998268, "currency": "USD", "enterpriseValue": -737689, "floatShares": 7181040, "sharesOutstanding": 28764600, "sharesShort": 65640, "sharesShortPriorMonth": 6665, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.18736, "heldPercentInstitutions": 0.2618, "shortRatio": 0.12, "shortPercentOfFloat": 0.0057, "bookValue": 0.441, "priceToBook": 0.5115646, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -14924166, "trailingEps": -1.23, "forwardEps": -0.75, "enterpriseToRevenue": -1.177, "enterpriseToEbitda": 0.097, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "AZTR", "underlyingSymbol": "AZTR", "shortName": "Azitra Inc", "longName": "Azitra, Inc.", "firstTradeDateEpochUtc": 1687267800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "e7445f64-9918-3241-b1f1-a0f95f2c4b08", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.2256, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.5, "targetMedianPrice": 3.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 4400327, "totalCashPerShare": 0.364, "ebitda": -7604685, "totalDebt": 959201, "quickRatio": 3.064, "currentRatio": 3.346, "totalRevenue": 626500, "debtToEquity": 17.989, "revenuePerShare": 0.151, "returnOnAssets": -0.57408, "returnOnEquity": -3.7964, "freeCashflow": -4846601, "operatingCashflow": -6951654, "revenueGrowth": 5.406, "grossMargins": 1.0, "operatingMargins": -6.4169, "financialCurrency": "USD", "trailingPegRatio": null}]